5
Views
4
CrossRef citations to date
0
Altmetric
Original Article

“As Needed” Pharmacotherapy Combined With Stimulus Control Treatment in Chronic Insomnia-Assessment of a Novel Intervention Strategy in a Primary Care Setting

, , &
Pages 1-7 | Published online: 04 Dec 2011

References

  • Ganguli M, Reynolds CF, Gilby JE: Prevalence and persistence of sleep complaints in a rural older community sample: The MoVIES project. JAGS 1996; 44:778–784
  • Hohagen F, Rink K, Kappler C, Schramm E, Riemann D, Weyerer S, Berger M: Prevalence and treatment of insomnia in general practice. A longitudinal study. Eur Arch Psychiatry Clin Neurosci 1993; 242(6):329–336
  • Wittchen HU, Krause P, Höfler M, Pittrow D, Winter S, Spiegel B, Hajak G, Riemann D, Steiger H, Pfister H: N1SAS-2000. Nationwide Insomnia Screening and Awareness Study. Nervenheilkunde 2001; 20:4–16
  • Simen S, Hajak G, Schlaf G, Westenhofer J, Rodenbeck A, Bandelow B, Pudel V, Rather E: Chronic sleep complaints. Results of a representative survey in Germany. Nervenarzt 1995; 66:686–695
  • Katz DA, McHorney CA: Clinical correlates of insomnia in patients with chronic illness. Arch Intern Med 1998; 158(10):1099–1107
  • Usttin T, Privett M, LeCrubier Y, Weiller E, Simon G, Korten A, Bassett S, Maier W, Sartorius N: Form, frequency, and burden of sleep problems in general health care. Eur J Psychiatry 1996; 11\(Suppl 1):5S–10S
  • Hohagen F, Kappler C, Schramm E, Riemann D, Weyerer S, Berger M: Sleep onset insomnia, sleep maintaining insomnia and insomnia with early morning awakening-temporal sta-bility of subtypes in a longitudinal study on general practice Wenders. Sleep 1994; 17:551–554
  • World Psychiatric Association: Task force on sedative hyp-notics: A Report. Eur Psychiatry 1993; 8:45–49
  • National Institutes of Health, Consensus Development State-ment: The treatment of sleep disorders of older people. Sleep 1991; 14:169–177
  • National Institute of Mental Health, Consensus Development Conference: Drugs and insomnia: The use of medications to promote sleep. J Am Med Assoc 1984; 251:2410–2414
  • Clarenbach P, Steinberg R, Wee8 HG, Berger M: Recommen-dations for the diagnosis and therapy of insomnia. Nervenarzt 1995; 66:723–729
  • Collegium Internationale Neuro-Psychopharmacologicum, Task Force: Impact of neuro-pharmacology in the 1990s-Treatment strategies for anxiety disorders and insomnia. Eur Neuropsychopharmacol 1990; 2:167–169
  • Roth T, Hajak G, esttin B: Consensus for the pharmacologic management of insomnia in the new millenium, Int J Clin Pract 2001; 55:1–11
  • Holm KJ, Goa KL: Zolpidem: An update of its pharmacol-ogy, therapeutic efficacy and tolerability in the treatment of insomnia. Drugs 2000; 59(4):865–889
  • Salva P, Costa J: Clinical pharmacokinetics and pharmacody-namics of zolpidem. Clin Pharmacokinet 1995; 29:142–153
  • Kryger M, Salva P: Polysomnographic comparisons of zolpi-dem and benzodiazepines in healthy volunteers and insom-niacs. In: Freeman H, Puech AJ, Roth T, eds. Zolpidem: An Update of its Pharmacological Properties and Therapeu-tic Place in the Management of Insomnia. Paris: Elsevier; 1996:141–148
  • Vogel G, Poirrier R: Studies of effects following discontinua-tion of zolpidem treatment. In: Freeman H, Puech AJ, Roth T, eds. Zolpidem: An Update of its Pharmacological Properties and Therapeutic Place in the Management of Insomnia. Paris: Elsevier; 1996: 149–160
  • Soldatos CR, Dikeos DG, Whitehead A: Tolerance and re-bound insomnia with rapidly eliminated hypnotics: A meta-analysis of sleep laboratory studies. Int Clin Psychopharmacol 1999; 14(5):287–303
  • Cluydts R, Peeters K, De Bouyalsky I, Lavoisy J: Comparison of continuous versus intermittent administration of zolpidem in chronic insomniacs: A double-blind, randomised pilot study. J Int Med Research 1998; 26:13–24
  • Arbus L, Lavoisy J, Belin J, Soubrane C: Efficacy and safety of zolpidem 10 mg administered pro re nata (P.R.N.) during 4 weeks in patients with chronic insomnia. Eur Neuropsy-chopharmacol 1999; 9(5, Suppl):S309
  • Walsh JK, Roth T, Randazzo A, Erman M, Jamieson A, Scharf M, Schweitzer PK, Ware JC: Eight weeks of non-nightly use of zolpidem for primary insomnia. Sleep 2000; 23(8):1087–1096
  • Hajak G, Cluydts R, Declerck A, Estivill SE, Middleton A, Sonka K, Unden M: Continuous versus non-nightly use of zolpidem in chronic insomnia: Results of a large-scale, double-blind, randomized, outpatient study. Int Clin Psychopharmacol 2002; 17(1):9–17
  • American Psychiatric Association (APA): Diagnostic and Sta-tistical Manual of Mental Disorders, 4th edn. (DSM-IV). Washington, DC: APA; 1994
  • World Health Organization: Tenth revision of the interna-tional classification of diseases, chapter V (F): Mental and Behavioural Disorders (including disorders of psychological development). Clinical descriptions and guidelines. Geneva: World Health Organization; 1991
  • Bootzin RR, Epstein D, Wood JM: Stimulus control instruc-tions. In: Hauri P, ed. Case Studies in Insomnia. New York: Plenum; 1991:19–28
  • Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ: The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res 1989; 28:193–213
  • Association for Methodology, and Documentation in Psychia-try and Collegium Internationale Psychiatriae Scalarum, eds: Cinical Global Impressions Observer Rating Scale. Rating Scales for Psychiatry, European edn. Beltz, Weinheim: AMDP and CIPS; 1990
  • Jacobs GD, Rosenberg PA, Friedman R, Matheson J, Peavy GM, Domar AD, Benson H: Multifactor behavioral treatment of chronic sleep-onset insomnia using stimulus con-trol and the relaxation response. Behav Med 1993; 7(4):498–509
  • Lacks P, Bertelson AD, Sugerman J, Kunkel J: The treatment of sleep-maintenance insomnia with stimulus-control techniques. Behav Res Ther 1983; 21(3):291–295
  • Morin CM, Culbert JP, Schwartz SM. Nonpharmaco-logical interventions for insomnia: A meta-analysis of treatment efficacy. Am J Psychiatry 1994; 151(8):1172–1180
  • Soyka M, Bottlender R, Moller HJ: Epidemiological evidence for a low abuse potential of zolpidem. Pharmacopsychiatry 2000; 33:138–141
  • Scharf MB: Feasibility of an every-other-night regimen in insomniac patients: Subjective hypnotic effectiveness of quazepam, triazolam, and placebo. J Clin Psychiatry 1993; 54:33–38

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.